Poraive IV infusion 30mg, manufactured by Chugai Pharmaceutical, contains Polatuzumab vedotin (genetical recombination). This antibody-drug conjugate is used for the treatment of diffuse large B-cell lymphoma and functions by binding to CD79b on B-cells, leading to cell growth arrest and apoptosis. It is supplied as 30mg per bottle with YJ code 4291455D1022.
Poraive IV infusion 30mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).